DK1981908T3 - Ny FSH-glykosyleringsvariant D3N - Google Patents

Ny FSH-glykosyleringsvariant D3N

Info

Publication number
DK1981908T3
DK1981908T3 DK07716617.1T DK07716617T DK1981908T3 DK 1981908 T3 DK1981908 T3 DK 1981908T3 DK 07716617 T DK07716617 T DK 07716617T DK 1981908 T3 DK1981908 T3 DK 1981908T3
Authority
DK
Denmark
Prior art keywords
glycosylation variant
new
fsh glycosylation
new fsh
variant
Prior art date
Application number
DK07716617.1T
Other languages
English (en)
Inventor
Marco Muda
Xuliang Jiang
Sean D Mckenna
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of DK1981908T3 publication Critical patent/DK1981908T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK07716617.1T 2006-01-17 2007-01-16 Ny FSH-glykosyleringsvariant D3N DK1981908T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75948606P 2006-01-17 2006-01-17
PCT/US2007/001004 WO2007084441A2 (en) 2006-01-17 2007-01-16 Novel fsh glycosylation variant d3n

Publications (1)

Publication Number Publication Date
DK1981908T3 true DK1981908T3 (da) 2010-12-13

Family

ID=38163618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07716617.1T DK1981908T3 (da) 2006-01-17 2007-01-16 Ny FSH-glykosyleringsvariant D3N

Country Status (22)

Country Link
US (1) US7956034B2 (da)
EP (1) EP1981908B1 (da)
JP (1) JP2009523445A (da)
KR (1) KR20080094697A (da)
CN (1) CN101370825B (da)
AR (1) AR059054A1 (da)
AT (1) ATE487738T1 (da)
AU (1) AU2007207697B2 (da)
BR (1) BRPI0706628A2 (da)
CA (1) CA2633844A1 (da)
CY (1) CY1110953T1 (da)
DE (1) DE602007010425D1 (da)
DK (1) DK1981908T3 (da)
EA (1) EA013974B1 (da)
HR (1) HRP20100610T1 (da)
IL (1) IL192547A (da)
PL (1) PL1981908T3 (da)
PT (1) PT1981908E (da)
RS (1) RS51792B (da)
SI (1) SI1981908T1 (da)
WO (1) WO2007084441A2 (da)
ZA (1) ZA200805194B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE038947T2 (hu) * 2005-08-26 2018-12-28 Ares Trading Sa Eljárás glikozilált béta-interferon elõállítására
WO2007065918A2 (en) * 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
BRPI0620223A2 (pt) * 2005-12-22 2011-11-01 Serono Lab mutantes de fsh
WO2009053358A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying fc-fusion proteins
AU2008314689A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying an Fc-containing protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058957A2 (en) * 1997-06-25 1998-12-30 Applied Research Systems Ars Holding N.V. Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
AU2002368265B2 (en) * 2001-10-22 2007-06-07 Merck Serono Sa Mutant glycoproteins
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
WO2007065918A2 (en) * 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant

Also Published As

Publication number Publication date
EA013974B1 (ru) 2010-08-30
WO2007084441A2 (en) 2007-07-26
PT1981908E (pt) 2010-11-23
IL192547A (en) 2012-04-30
DE602007010425D1 (de) 2010-12-23
CY1110953T1 (el) 2015-06-11
SI1981908T1 (sl) 2011-01-31
EA200870177A1 (ru) 2009-02-27
ZA200805194B (en) 2009-10-28
AU2007207697A1 (en) 2007-07-26
US20080280832A1 (en) 2008-11-13
ATE487738T1 (de) 2010-11-15
CN101370825A (zh) 2009-02-18
AR059054A1 (es) 2008-03-12
HRP20100610T1 (hr) 2010-12-31
IL192547A0 (en) 2009-02-11
AU2007207697B2 (en) 2012-01-19
RS51792B (en) 2011-12-31
KR20080094697A (ko) 2008-10-23
EP1981908B1 (en) 2010-11-10
PL1981908T3 (pl) 2011-04-29
US7956034B2 (en) 2011-06-07
CA2633844A1 (en) 2007-07-26
JP2009523445A (ja) 2009-06-25
CN101370825B (zh) 2012-10-10
WO2007084441A3 (en) 2007-09-07
EP1981908A2 (en) 2008-10-22
AU2007207697A2 (en) 2008-07-31
BRPI0706628A2 (pt) 2011-04-05

Similar Documents

Publication Publication Date Title
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
ES1065656Y (es) Helicoptero
AT504580A3 (de) Scan-einrichtung
DK1849352T3 (da) Mejetærsker
ATE546437T1 (de) Aminomethyl-4-imidazole
ES2896053T8 (es) Biogel
DE502007000218D1 (de) nsetzungen
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
FR2899996B1 (fr) Disjoncteur.
DE602006000836D1 (de) Leitungssteuerungsanordnung
DE502006006067D1 (de) Ng
DE502007001629D1 (de) Rfahren
DE502007000361D1 (de) Stanznieteinheit
DE102006045567A8 (de) Crimpstabilisierung
DE112007003147A5 (de) Rohr-Biegevorrichtung
DE502007001652D1 (de) Notöltank
DE502007005975D1 (de) Wischblatt
BRPI0719956A2 (pt) Radiofluoração
DE502007006319D1 (de) Staubabsaugadaptervorrichtung
DK1981908T3 (da) Ny FSH-glykosyleringsvariant D3N
DE112007001125A5 (de) Käfigmutter
DE502007003774D1 (de) Werkzeugaufnahme
DE502007001097D1 (de) Lenkeranordnung